| http://www.w3.org/ns/prov#value | - and CPT-11 synergismEP2050335A19 Feb 200722 Apr 2009Genentech, Inc.Gene disruptions, compositions and methods relating theretoEP2052742A114 Jun 200129 Apr 2009Biogen Idec Inc.Treatment of B-cell associated diseases such as malignancies and autoimmune diseases using a cold anti-CD20 antibody/radiolabeled anti-CD22 antibody combinationEP2058334A210 Jun 199913 May 2009Genentech, Inc.Monoclonal antibo
|